József Erfán
- Oncology top 2%
- Otorhinolaryngology top 0.2%
- Pulmonary and Respiratory Medicine top 2%
- Surgery top 5%
- Molecular Biology
- Co-authors
- Ricard Mesı́aFrédéric PeyradeÉva RemenárDidier CupissolAndrzej KaweckiSylvie RotteyArmin SchuelerFernando Rivera
- Topics
- Lung Cancer Treatments and Mutations (3 papers)Head and Neck Cancer Studies (3 papers)Protein Degradation and Inhibitors (2 papers)
In The Last Decade
József Erfán
6 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 1.5k
- Otorhinolaryngology 1.4k
- Pulmonary and Respiratory Medicine 1.2k
- Surgery 769
- Molecular Biology 614
Countries citing papers authored by József Erfán
This map shows the geographic impact of József Erfán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by József Erfán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites József Erfán more than expected).
Fields of papers citing papers by József Erfán
This network shows the impact of papers produced by József Erfán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by József Erfán. The network helps show where József Erfán may publish in the future.
Co-authorship network of co-authors of József Erfán
This figure shows the co-authorship network connecting the top 25 collaborators of József Erfán. A scholar is included among the top collaborators of József Erfán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with József Erfán. József Erfán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | First-line bevacizumab-paclitaxel in 220 patients with metastatic breast cancer: results from the AVAREG study. | 11 |
| 3 | 6 | |
| 4 | Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancerbreakdown → | 2594 |
| 5 | 7 | |
| 6 | 1 |
About József Erfán
József Erfán is a scholar working on Otorhinolaryngology, Radiological and Ultrasound Technology and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Head and Neck Cancer Studies (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Otorhinolaryngology (1.4k citations), Oncology (1.5k citations) and Pulmonary and Respiratory Medicine (1.2k citations). József Erfán has collaborated with scholars based in Hungary, Spain and France. Frequent co-authors include Ricard Mesı́a, Frédéric Peyrade, Éva Remenár, Didier Cupissol, Andrzej Kawecki, Sylvie Rottey, Armin Schueler, Fernando Rivera, Nadia Amellal and Carsten Bokemeyer. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Acta Oto-Laryngologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.